Controlled release of artemisone for the treatment of experimental cerebral malaria

BACKGROUND: Cerebral malaria (CM) is a leading cause of malarial mortality resulting from infection by Plasmodium falciparum. Treatment commonly involves adjunctive care and injections or transfusion of artemisinins. All artemisinins that are in current use are metabolized to dihydroxyartemisinin (D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Parasit Vectors
Main Authors: Golenser, Jacob, Buchholz, Viola, Bagheri, Amir, Nasereddin, Abed, Dzikowski, Ron, Guo, Jintao, Hunt, Nicholas H., Eyal, Sara, Vakruk, Natalia, Greiner, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5333427/
https://ncbi.nlm.nih.gov/pubmed/28249591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-017-2018-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados